General Information of the Compound
Compound ID
CP0522400
Compound Name
Ac-D-Nal-[D-(pCl)Phe]-D-Pal-Ser-Tyr-D-Har(Et2)-Leu-Har(Et2)-Pro-DAla-NH2
    Show/Hide
Synonyms
Antagon (TN)
Ganirelix
Ganirelix (INN)
Ganirelix [INN:BAN]
Ganirelix acetate
Ganirelixum
Ganirelixum [INN-Latin]
Orgalutran
Orgalutran (TN)
RS-26306
    Show/Hide
Structure
Formula
C80H113ClN18O13
Molecular Weight
1570.35
Canonical SMILES
CCNC(NCCCC[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(NCC)=NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O)=NCC
    Show/Hide
InChI
InChI=1S/C80H113ClN18O13/c1-9-84-79(85-10-2)88-38-17-15-24-60(70(104)94-62(41-49(5)6)71(105)93-61(25-16-18-39-89-80(86-11-3)87-12-4)78(112)99-40-20-26-68(99)77(111)90-50(7)69(82)103)92-73(107)64(44-53-30-35-59(102)36-31-53)97-76(110)67(48-100)98-75(109)66(46-55-21-19-37-83-47-55)96-74(108)65(43-52-28-33-58(81)34-29-52)95-72(106)63(91-51(8)101)45-54-27-32-56-22-13-14-23-57(56)42-54/h13-14,19,21-23,27-37,42,47,49-50,60-68,100,102H,9-12,15-18,20,24-26,38-41,43-46,48H2,1-8H3,(H2,82,103)(H,90,111)(H,91,101)(H,92,107)(H,93,105)(H,94,104)(H,95,106)(H,96,108)(H,97,110)(H,98,109)(H2,84,85,88)(H2,86,87,89)/t50-,60-,61+,62+,63-,64+,65-,66-,67+,68+/m1/s1
    Show/Hide
InChIKey
GJNXBNATEDXMAK-PFLSVRRQSA-N
CAS
124904-93-4
Physicochemical Property
logP
2.2727
Rotatable Bonds
44
Heavy Atom Count
112
Polar Areas
451.49
Hydrogen Bond Donor Count
16
Hydrogen Bond Acceptor Count
16
Complexity
112

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16130957
SID: 14793014
ChEMBL ID
CHEMBL1251
DrugBank ID
DB06785
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01836, Gonadotropin-releasing hormone receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 3.6 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Ganirelix )
Drug Name Ganirelix
Company Organon International
Indication
Ovulation dysfunction
Approved
Target(s)
Gonadotropin-releasing hormone receptor (GNRHR)
Antagonist